Hyun W. Bae serves as Executive at Kairos Pharma, LTD., where they oversee executive responsibilities. Since joining the company, Hyun W. Bae has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 8, 2025 involved receiving (via award) 19,084 shares valued at $0.
Hyun W. Bae currently holds 73,370 shares of Kairos Pharma, LTD. (KAPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hyun W. Bae has been a net neutral trader of KAPA stock. They have purchased $0 and sold $0 worth of shares.
Hyun W. Bae's most recent insider trade was on Oct 8, 2025, when they sold 19,084 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |